First, both used slow dose escalation specifically because the gastrointestinal effects are dose-related
Direct comparison across multiple quality dimensions reveals relative strengths and weaknesses
Indirect Causes Shedding can stem from more than just the drug
( BE ) Plasma DPP-4 activity before (time 30 minutes) and 90 minutes after oral gavage of water or sitagliptin as indicated ( B , n = 914/group), plasma TG and AUC over 3 hours ( C , n = 914/group), and apoB48 and apoB100 protein levels measured by Western blot (WB) ( D and E , n = 35/group) after oral gavage of water or sitagliptin, followed by i.v
Whether the addition of glucagon receptor agonism in retatrutide meaningfully alters the overall GI side effect burden compared with approved agents remains uncertain
That appears to be true in Phase 2